Hello,
We have a case of a 43 yrs old female with metastatic brain mets from inflammatory bilateral breast. Last May we treated 15 brain mets with CK. She had an overall great response, but she now presents with 1 new lesion and 1 lesion with progression. Luckily both lesions are in the Frontal lobe and far from any OARs. We were planning to do 30Gy/5fx. Are there any thoughts on a different approach for prescription in this case? What is your clinics policy with retreatment for brain in regard to dose and normal brain constraints?
Thank you and I look forward to any feedback.
Join us in Warsaw on June 24th, 2025, for the Brainlab Central Europe SRS & SBRT Symposium 2025. Experience an inspiring lineup of expert talks and engaging discussions on cutting-edge developments in radiotherapy and radiosurgery.
Highlights of the symposium:
- Discover advancements: Attend scientific talks and explore the latest techniques in precision, personalization, and standardization of SRS & SBRT.
- Join interactive sessions: Take part in live demonstrations and dynamic discussions that will shape the future of patient care.
- Network with experts: Engage with leading professionals in the field and connect with peers from across Central Europe.
We look forward to welcoming you to Warsaw this June! Click here to learn more: Welcome | Brainlab
Join us in Brussels for a vibrant evening with insightful clinical talks by renowned clinical experts and inspirational discussions on SRS & SBRT.
Experience cutting edge of radiotherapy and radiosurgery at our exciting sunset symposium focused on precision, personalization, and standardization in Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT). This event will bring together clinicians, medical physicists, and radiation oncologists to share valuable clinical techniques and innovative management strategies, as well as insights into the transformative impact of big data in the field of SRS & SBRT.
We look forward to welcoming you to Brussels for this inspiring event! Click here to learn more: Welcome | Brainlab
Wir laden Sie herzlich ein zu unserem DACH Radiotherapie Symposium zum Thema Präzision, Personalisierung und Standardisierung in der stereotaktischen Radiochirurgie und Radiotherapie am 24. Januar 2025 im Brainlab Headquarter in München.
Klinische Anwender:innen und Fachkolleg:innen werden Erfahrungen und Fallstudien aus dem klinischen Alltag präsentieren und freuen sich auf spannende Diskussionen sowie den Austausch mit Ihnen.
Mehr information hier
Join the Symposium!
The Brainlab UK & Ireland Radiotherapy Symposium 2024 will focus on precision, personalization and evolution in radiotherapy and radiosurgery.
Led by the Charing Cross Hospital team, this meeting is an opportunity for clinicians, medical physicists and radiation oncologists to share insights on clinical techniques, exchange management approaches, tools and the use of big data in radiotherapy and radiosurgery treatments.
Attendees have the opportunity to take part in scientific talks, live demonstrations and informative discussions.
We look forward to seeing you all in London!
To register click here
We’re pleased to host the Advanced Clinical Course “Brain Metastases and Skull-base Tumors” in cooperation with Centre Hospitalier Princesse Grace and the team of Dr. Cécile Ortholan and Benjamin Serrano, PhD.
This Advanced Clinical Course will provide participants with the opportunity to learn from clinical experts about the clinical implementation and requirements for a successful radiosurgery program for brain metastases and skull-base tumors. During the course, medical physicists will learn about specific quality assurance techniques as well as expert tricks for treatment planning with Brainlab radiosurgery software. Radiation oncologists and neurosurgeons will learn about contouring, clinical prescriptions and planning approaches.
More information here
Interested? Contact your local Brainlab Sales representative.
*Please note: A Brainlab Academy ticket is needed to be able to attend this course.
You are being invited to take part in a 15-minute survey assessing how radiation therapy and radiosurgery departments (including C-arm Linacs, Gammaknife, CyberKinfe, etc) , utilise MRI fibertracking (also known as MRI tractography) in their practice. (Link below)
This study is being run by Physical Sciences Department of Peter MacCallum Cancer Centre, Melbourne, Australia.
Upon request, we will provide you with the full anonymised survey results so that you can compare your practice with other participants.
This project has been approved by the Peter MacCallum Cancer Centre Ethics Committee (ethics@petermac.org).
If you have any questions, please don’t hesitate to send an email.
Participation agreement:
By clicking the link below, I agree to participate in this survey.
https://redcap.petermac.org.au/surveys/?s=AP4884J787EJRTLF
Thanks
Are you attending ESTRO this year? If so, don't miss Manuel Todorovic's stage talk.
🎙️Stage Talk, a pioneering presentation on Model-based VMAT Automation for Elements Multiple Brain Mets SRS by Manuel Todorovic, University Medical Center Hamburg-Eppendorf, Germany on May 4th from 4:30 - 4:45 PM BST at the ESTRO stage.
